Immune activation in non-treated suicidal major depression

Immunology Letters

Volumn 67, Issue 2, 1999, Pages 105-108

  Mendlovic, Shlomo ^a   Mozes, Edna ^b   Eilat, Eran ^b   Doron, Adiel ^a   Lereya, Joseph ^a   Zakuth, Vera ^c   Spirer, Zvi ^c,d  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Dana Children's Hospital   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Depression; Immune activation; NK cells; Suicide

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HELPER CELL; HUMAN; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDE; T LYMPHOCYTE;

CYTOKINES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SUICIDE; TH1 CELLS; TH2 CELLS;

EID: 0033119218     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00145-X     Document Type: Article

References (14)

1. Evans D.L., Folds J.D., Petitto J.M., Golden R.N., Pedersen C.A., Corrigan M., Gilmore J.H., Silva S.G., Quade D., Ozer H. Circulating natural killer cell phenotypes in men and women with major depression: relation to cytotoxic activity and severity of depression. Arch. Gen. Psychiatry. 49:1992;388-395.
2. Anesi A., Franciotta D., Di-Paolo E., Zardini E., Melzi-d'Eril G.V., Zerbi F. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorder. Funct. Neurol. 9:1994;17-22.
3. Maes M., Meltzer H., Jacobs J., Suy E., Calabrese J., Minner B., Raus J. Autoimmunity in depression: increased anti-phopholipid autoantibodies. Acta Psychiatr. Scand. 87:1993;160-166.
4. Maes M., Stevens W., DeClerck L., Bridts C., Peeters D., Schotte C., Cosyns P. Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr. Scand. 86:1992;423-431.
5. van Dam A.P., Wekking E.M., Callewaert J.A., Schipperijn A.J., Oomen H.A., de Jong J., Swaak A.J., Smeenk R.J., Feltkamp T.E. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol. Int. 14:1994;57-62.
6. Mendlovic S., Doron A., Eilat E. Can depressive patients exploit the immune system for suicide? Med. Hypotheses. 49:1997;445-446.
7. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA. 95:1998;3239-3244.
8. de La Rocque L., Campos M.M., Olej B., Castilho F., Mediano I.F., Rumjanek V.M. Inhibition of human LAK-cell activity by the anti-depressant trifluoperazine. Immunopharmacology. 29:1995;1-10.
9. Segal R., Bermas B.L., Dagan M., Kalush F., Sheorer G.M., Mozes E. Kinetics of cytokine production in experimental systemic lupus erythmatosus. J. Immunol. 158:1997;3009-3016.
10. Mosmann T.R. Two types of murine T-cell clones I: definition according to profiles of lymphokine activities abd selected proteins. J. Immunol. 136:1986;2348-2357.
11. Kelso A. Th1 and Th2 subsets: paradigm lost? Immunol Today. 16:1995;374-379.
12. Carlton B., Lafferty K.J. The Th1/Th2 balance in autoimmunity. Curr. Opinion Immunol. 7:1995;793-798.
13. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental allergic encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
14. Katz J.K., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.